Home / Opium Derivatives and Expectorants / Norway
NO ATC R05FA02 · updated 2 Nov 2026
Opium Derivatives and Expectorants shortage in Norway
Is there an Opium Derivatives and Expectorants shortage in Norway?
Yes. As of 2 Nov 2026, 1 Opium Derivatives and Expectorants product is reported short in Norway, the first since 22 Jun 2026. The company estimate for the return is 18 Dec 2026. Main reason: regulatory or licensing.
Also short in Canada. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Solvipect Comp 2,5 mg/ml/5 mg/ml mikstur, oppløsning, 100 ml flaske av glass | Orifarm Healthcare A/S | 22 Jun 2026 | 18 Dec 2026 | Regulatory or licensing Regulatoriske problemer/utfordringer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).